SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

B

BDX

Becton, Dickinson and Company

$167.12

-2.82 (-1.66%)

Summary

Stories

News

Metrics

Fundamentals

Current Market Valuation

Current Price

$167.12

Live market price

P/E (TTM)

27.26

EPS: $6.13

P/S (TTM)

2.17

Price to Sales

TTM Quarters

4

Quarters included in TTM

Updated: 3/8/2026, 5:56:16 AM

Historical Trends

Range:

Revenue Over Time

Q2 2021Q3 2022Q4 2023Q1 2026$0B$2B$4B$6B$8B

Net Income Over Time

Q2 2021Q3 2022Q4 2023Q1 2026$0B$0B$0B$1B$1B

Short Interest (% of Float) Over Time

02/2805/3008/2902/130.0%5.0%10.0%15.0%20.0%High SI

Short Interest

14.6M

% of Float

5.1%

Days to Cover

3.8

Avg Daily Vol

3.9M

Historical income statement data up to 5 years


Historical SEC Filings

Report Period

Debt/Equity

0.82

Leverage ratio

ROE (TTM)

6.95%

Return on equity

Income Statement

Revenue

$5.25B


Cost of Revenue

$2.84B


Gross Profit

$2.41B


Operating Income

$552.00M


Net Income

$382.00M


EPS (Quarter)

$1.34


EPS (TTM)

$6.13

Balance Sheet

Total Assets

$54.84B


Total Liabilities

$29.56B


Shareholders' Equity

$25.28B


Current Assets

$9.19B


Current Liabilities

$8.76B


Cash & Equivalents

--


Long-Term Debt

--

Cash Flow

Operating Cash Flow

$657.00M


Investing Cash Flow

$-183.00M


Financing Cash Flow

$-302.00M


Free Cash Flow

$474.00M

Profitability Margins

Gross Margin

45.91%

Operating Margin

10.51%

Net Profit Margin

7.27%


ROA (TTM)

3.20%


ROE (TTM)

6.95%

Data source: Polygon.io

Last updated: 3/8/2026, 5:56:16 AM

Company Profile

Symbol

BDX


Market Cap

$47.54B


IPO Date

Sep 25, 1963


CEO

--


Employees

72,000


Sector

--


Industry

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS


Country

United States


Exchange

--

Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.

Read More

Similar Stocks

TMO

Thermo Fisher Scientific Inc.

$501.97

-3.25%

SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy